Identification of a Novel Renal Metastasis Associated CpG-Based DNA Methylation Signature (RMAMS)

Approximately 21% of patients with renal cell cancer (RCC) present with synchronous metastatic disease at the time of diagnosis, and metachronous metastatic disease occurs in 20–50% of cases within 5 years. Recent advances in adjuvant treatment of aggressive RCC following surgery suggest that biomar...

Descripción completa

Detalles Bibliográficos
Autores principales: Serth, Jürgen, Peters, Inga, Katzendorn, Olga, Dang, Tu N., Moog, Joana, Balli, Zarife, Reese, Christel, Hennenlotter, Jörg, Grote, Alexander, Lafos, Marcel, Tezval, Hossein, Kuczyk, Markus A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569431/
https://www.ncbi.nlm.nih.gov/pubmed/36232491
http://dx.doi.org/10.3390/ijms231911190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569431/
https://www.ncbi.nlm.nih.gov/pubmed/36232491
http://dx.doi.org/10.3390/ijms231911190

Ejemplares similares